Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Comparative analysis of mutant tyrosine kinase chemical rescue.

Muratore KE, Seeliger MA, Wang Z, Fomina D, Neiswinger J, Havranek JJ, Baker D, Kuriyan J, Cole PA.

Biochemistry. 2009 Apr 21;48(15):3378-86. doi: 10.1021/bi900057g.

PMID:
19260709
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Chemical rescue of a mutant protein-tyrosine kinase.

Williams DM, Wang D, Cole PA.

J Biol Chem. 2000 Dec 8;275(49):38127-30.

PMID:
11006267
[PubMed - indexed for MEDLINE]
Free Article
3.

Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail.

Wang D, Huang XY, Cole PA.

Biochemistry. 2001 Feb 20;40(7):2004-10.

PMID:
11329267
[PubMed - indexed for MEDLINE]
5.

Domain interactions in protein tyrosine kinase Csk.

Sondhi D, Cole PA.

Biochemistry. 1999 Aug 24;38(34):11147-55.

PMID:
10460171
[PubMed - indexed for MEDLINE]
6.

Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).

Lee S, Ayrapetov MK, Kemble DJ, Parang K, Sun G.

J Biol Chem. 2006 Mar 24;281(12):8183-9. Epub 2006 Jan 26.

PMID:
16439366
[PubMed - indexed for MEDLINE]
Free Article
7.

Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.

Jackson PK, Paskind M, Baltimore D.

Oncogene. 1993 Jul;8(7):1943-56.

PMID:
8510937
[PubMed - indexed for MEDLINE]
8.

Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations.

Seeliger MA, Ranjitkar P, Kasap C, Shan Y, Shaw DE, Shah NP, Kuriyan J, Maly DJ.

Cancer Res. 2009 Mar 15;69(6):2384-92. doi: 10.1158/0008-5472.CAN-08-3953. Epub 2009 Mar 10.

PMID:
19276351
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Functions of the activation loop in Csk protein-tyrosine kinase.

Lin X, Lee S, Sun G.

J Biol Chem. 2003 Jun 27;278(26):24072-7. Epub 2003 Apr 9.

PMID:
12686554
[PubMed - indexed for MEDLINE]
Free Article
10.

Regulation of the c-Abl and Bcr-Abl tyrosine kinases.

Hantschel O, Superti-Furga G.

Nat Rev Mol Cell Biol. 2004 Jan;5(1):33-44. Review.

PMID:
14708008
[PubMed - indexed for MEDLINE]
11.

Structural basis for the recognition of c-Src by its inactivator Csk.

Levinson NM, Seeliger MA, Cole PA, Kuriyan J.

Cell. 2008 Jul 11;134(1):124-34. doi: 10.1016/j.cell.2008.05.051.

PMID:
18614016
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Structural basis for selective inhibition of Src family kinases by PP1.

Liu Y, Bishop A, Witucki L, Kraybill B, Shimizu E, Tsien J, Ubersax J, Blethrow J, Morgan DO, Shokat KM.

Chem Biol. 1999 Sep;6(9):671-8.

PMID:
10467133
[PubMed - indexed for MEDLINE]
Free Article
13.

The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.

Williams JC, Weijland A, Gonfloni S, Thompson A, Courtneidge SA, Superti-Furga G, Wierenga RK.

J Mol Biol. 1997 Dec 19;274(5):757-75.

PMID:
9405157
[PubMed - indexed for MEDLINE]
14.

Reciprocal regulation of Abl and receptor tyrosine kinases.

Srinivasan D, Kaetzel DM, Plattner R.

Cell Signal. 2009 Jul;21(7):1143-50. doi: 10.1016/j.cellsig.2009.03.003. Epub 2009 Mar 9.

PMID:
19275932
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK.

Mikkola ET, Bergman M.

FEBS Lett. 2003 Jun 5;544(1-3):11-4.

PMID:
12782282
[PubMed - indexed for MEDLINE]
Free Article
16.

Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions.

Weng Z, Rickles RJ, Feng S, Richard S, Shaw AS, Schreiber SL, Brugge JS.

Mol Cell Biol. 1995 Oct;15(10):5627-34.

PMID:
7565714
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Sequence specificity of C-terminal Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and Lyn.

Ruzzene M, Songyang Z, Marin O, Donella-Deana A, Brunati AM, Guerra B, Agostinis P, Cantley LC, Pinna LA.

Eur J Biochem. 1997 Jun 1;246(2):433-9.

PMID:
9208935
[PubMed - indexed for MEDLINE]
Free Article
18.

Two distinct phosphorylation pathways have additive effects on Abl family kinase activation.

Tanis KQ, Veach D, Duewel HS, Bornmann WG, Koleske AJ.

Mol Cell Biol. 2003 Jun;23(11):3884-96.

PMID:
12748290
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty.

Seeliger MA, Nagar B, Frank F, Cao X, Henderson MN, Kuriyan J.

Structure. 2007 Mar;15(3):299-311.

PMID:
17355866
[PubMed - indexed for MEDLINE]
Free Article
20.

Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.

Shekhtman A, Ghose R, Wang D, Cole PA, Cowburn D.

J Mol Biol. 2001 Nov 16;314(1):129-38.

PMID:
11724538
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk